Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 10, pp. 1229-1243
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Genetics of glycosylation in mammalian development and disease
Pamela Stanley
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 17
Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer
Ingmar F. Rompen, Joseph R. Habib, Christopher L. Wolfgang, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 489-489
Open Access | Times Cited: 8
Hereditary Pancreatic Cancer: Advances in Genetic Testing, Early Detection Strategies, and Personalized Management
Carmen Blanco Abad, Paula Gomila Pons, S. Campos Ramírez, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 367-367
Open Access | Times Cited: 1
The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer
Ahmed A. Ahmed, William Greenhalf, Daniel H. Palmer, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2452-2452
Open Access | Times Cited: 17
Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery
Junyu Wu, Guping Tang, Chien‐shan Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Screening for pancreatic cancer has the potential to save lives, but is it practical?
Benjamin L. Mazer, Jae W. Lee, Nicholas J. Roberts, et al.
Expert Review of Gastroenterology & Hepatology (2023) Vol. 17, Iss. 6, pp. 555-574
Open Access | Times Cited: 14
PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC
Antonella Farina, Sara Tartaglione, Adele Preziosi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3498-3498
Open Access | Times Cited: 4
The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal
Pradeep S. Virdee, Kiana Collins, Claire Friedemann Smith, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1692-1692
Open Access | Times Cited: 4
Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development
Laura Kane, Gregory S. Mellotte, Eimear Mylod, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma
Takeshi Terashima, Kouki Nio, Naohiko Koshikawa, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Chewing the fat: How lipidomics is changing our understanding of human health and disease in 2022
Caroline Géhin, Stephen J. Fowler, Drupad K. Trivedi
Analytical Science Advances (2023) Vol. 4, Iss. 3-4, pp. 104-131
Open Access | Times Cited: 10
Emerging Horizons in the Diagnosis of Pancreatic Cancer: The Role of Circulating microRNAs as Early Detection Biomarkers for Pancreatic Ductal Adenocarcinoma
Ibrahim Reyaz, Bilal Khan, Neha James, et al.
Cureus (2024)
Open Access | Times Cited: 3
Efficacy of adding levofloxacin to gemcitabine and nanoparticle-albumin-binding paclitaxel combination therapy in patients with advanced pancreatic cancer: study protocol for a multicenter, randomized phase 2 trial (T-CORE2201)
Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
Abinaya Elango, Vineeta Debbie Nesam, Padmaja Sukumar, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 3
High Sensitivity and Specificity Platform to Validate MicroRNA Biomarkers in Cancer and Human Diseases
Anastassia Kanavarioti, M. Hassaan Rehman, Salma Qureshi, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 4, pp. 42-42
Open Access | Times Cited: 3
Development of a fit-for-purpose multi-marker panel for early diagnosis of pancreatic ductal adenocarcinoma
Hyeonji Kim, Sunghyun Huh, Jungkap Park, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 9, pp. 100824-100824
Open Access | Times Cited: 3
Determining the feasibility of calculating pancreatic cancer risk scores for people with new-onset diabetes in primary care (DEFEND PRIME): study protocol
Hugh Claridge, Claire A. Price, Rofique Ali, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e079863-e079863
Open Access | Times Cited: 1
GDF15 and LCN2 for early detection and prognosis of pancreatic cancer
Xinxia Zhu, Brennan Olson, Dove Keith, et al.
Translational Oncology (2024) Vol. 50, pp. 102129-102129
Open Access | Times Cited: 1
Electrochemical immunoplatform to help managing pancreatic cancer
Víctor Pérez‐Ginés, Rebeca M. Torrente‐Rodríguez, Marı́a Pedrero, et al.
Journal of Electroanalytical Chemistry (2023) Vol. 935, pp. 117312-117312
Open Access | Times Cited: 3
Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumors
Ji Hye Jeong, Su‐Jin Park, Sang Yeon Lee, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110451-110451
Open Access | Times Cited: 3
Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses
Jennifer Moran, Eimear Mylod, Laura Kane, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 360-360
Open Access | Times Cited: 2
Combining prognostic value of serum carbohydrate antigen 19-9 and tumor size reduction ratio in pancreatic ductal adenocarcinoma
Dongqin Xia, Yong Zhou, Shuang Yang, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 3, pp. 798-809
Open Access
Analytical platform to validate microRNA biomarkers for cancer or disease with practically 100% sensitivity and specificity
Anastassia Kanavarioti, M. Hassaan Rehman, Salma Qureshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection
Alexander Ney, Nuno R. Nené, Eva Sedlak, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 8, pp. e1012408-e1012408
Open Access
Page 1 - Next Page

Scroll to top